A young woman has just lodged a complaint against the laboratory because she believes that her stroke is linked to her 3rd generation pill. And she blames the Medicines Agency.
Marion Larat will go all the way. This Friday, this woman filed a complaint against the director of the Bayer laboratory. The National Medicines Safety Agency (Ansm) is also targeted. Victim of a stroke, this 25-year-old young woman blames the 3rd generation pill she was using. Marion Larat wonders why these pills remain in circulation when they are, according to her, the cause of her stroke.
Last October, the Minister of Health announced the delisting of 3rd generation pills from September 30, 2013. Marisol Touraine then followed the recommendation of the High Authority of Health (HAS) which had argued a risk of venous thrombosis twice as high with the latest generation pills.
A finding confirmed by the Euorpean Medicines Agency based on a review of scientific literature. A maximum risk, specified the French Agency last October, in the first year of use of a combined oral contraceptive (COC, 2nd, 3rd and 4th generation pill) or when resuming a COC. But, “this risk remains very rare”, added the Ansm, and “the benefit / risk ratio of COCs remains positive”.
Consequently, the Ansm recommended that physicians prescribe second-generation COCs as first-line treatment and indicated that women who have been used for a long time to a third-generation COC could continue to use it if no risk factor for thrombosis is present. ‘was identified. The Agency was the subject of a referral from Marisol Touraine for a reassessment of the benefits / risks of 3rd generation COCs. The Minister also approached the HAS to establish recommendations specifying the correct therapeutic strategy in terms of contraception.
.
